A Novel Synthetic Dihydroindeno[1,2-b] Indole Derivative (LS-2-3j) Reverses ABCB1- and ABCG2-Mediated Multidrug Resistance in Cancer Cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel Synthetic Dihydroindeno[1,2-b] Indole Derivative (LS-2-3j) Reverses ABCB1- and ABCG2-Mediated Multidrug Resistance in Cancer Cells
Authors
Keywords
-
Journal
MOLECULES
Volume 23, Issue 12, Pages 3264
Publisher
MDPI AG
Online
2018-12-11
DOI
10.3390/molecules23123264
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The therapeutic potential of targeting ABC transporters to combat multi-drug resistance
- (2017) Piyush Bugde et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
- (2014) Qingcheng Mao et al. AAPS Journal
- Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
- (2014) Yulong Shang et al. CURRENT CANCER DRUG TARGETS
- Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
- (2014) Nagaraju Anreddy et al. MOLECULES
- Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
- (2014) Yu-Li Lo et al. PLoS One
- Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer
- (2014) Bo Gao et al. Scientific Reports
- Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo
- (2013) Huan Meng et al. ACS Nano
- Changes in the Expression of miR-381 and miR-495 Are Inversely Associated with the Expression of the MDR1 Gene and Development of Multi-Drug Resistance
- (2013) Yan Xu et al. PLoS One
- Increased JNK1 Signaling Pathway Is Responsible for ABCG2-Mediated Multidrug Resistance in Human Colon Cancer
- (2012) Ming Ming Zhu et al. PLoS One
- COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer
- (2011) Hua Sui et al. CARCINOGENESIS
- Knockdown of MRP4 by lentivirus-mediated siRNA improves sensitivity to adriamycin in adriamycin-resistant acute myeloid leukemia cells
- (2011) Bei Liu et al. CHINESE SCIENCE BULLETIN
- Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma
- (2011) Huiling Shen et al. EXPERIMENTAL HEMATOLOGY
- Multidrug resistance associated proteins in multidrug resistance
- (2011) Kamlesh Sodani et al. Chinese Journal of Cancer
- Multidrug Resistance Gene (MDR-1) and Risk of Brain Metastasis in Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
- (2010) Koji Matsuo et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Breast cancer resistance protein/ABCG2 is differentially regulated downstream of extracellular signal-regulated kinase
- (2009) Yasuo Imai et al. CANCER SCIENCE
- Potent and Selective Inhibitors of Breast Cancer Resistance Protein (ABCG2) Derived from thep-Glycoprotein (ABCB1) Modulator Tariquidar
- (2009) Matthias Kühnle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer
- (2008) Edith A. Perez BREAST CANCER RESEARCH AND TREATMENT
- Association of GSTP1 expression with resistance to docetaxel and paclitaxel in human breast cancers
- (2007) T. Arai et al. EJSO
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started